TRAIL receptor mediates inflammatory cytokine release in an NF-kappaB-dependent manner (Q39852876)

15 September 2017

TRAIL receptor mediates inflammatory cytokine release in an NF-kappaB-dependent manner (English)

1 reference

15 September 2017

0 references

0 references

Wanhu Tang

1

1 reference

15 September 2017

Weimin Wang

2

1 reference

15 September 2017

Yaxi Zhang

3

1 reference

15 September 2017

Shilian Liu

4

1 reference

15 September 2017

Yanxin Liu

5

1 reference

15 September 2017

Dexian Zheng

6

1 reference

15 September 2017

1 June 2009

1 reference

15 September 2017

1 reference

15 September 2017

19

1 reference

15 September 2017

6

1 reference

15 September 2017

758-767

1 reference

https://scigraph.springernature.com/pub.10.1038/cr.2009.57

15 September 2017

0 references

cites work

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

The receptor for the cytotoxic ligand TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

TRAIL receptor-2 signals apoptosis through FADD and caspase-8

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

Apo2L/TRAIL and immune regulation.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

Cutting Edge: TRAIL Deficiency Accelerates Hematological Malignancies

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

Normal thymocyte negative selection in TRAIL-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

TRAIL induces apoptosis and inflammatory gene expression in human endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

TRAIL Promotes the Survival and Proliferation of Primary Human Vascular Endothelial Cells by Activating the Akt and ERK Pathways

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

Modulation of tumor necrosis factor apoptosis-inducing ligand- induced NF-kappa B activation by inhibition of apical caspases

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

A novel anti-human DR5 monoclonal antibody with tumoricidal activity induces caspase-dependent and caspase-independent cell death

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

Two tumour necrosis factor receptors: structure and function.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L).

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-kappa B activity.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

Resistance of melanoma cells to TRAIL does not result from upregulation of antiapoptotic proteins by NF-kappaB but is related to downregulation of initiator caspases and DR4.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

Critical link between TRAIL and CCL20 for the activation of TH2 cells and the expression of allergic airway disease

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.57

7 January 2021

Identifiers

DOI

10.1038/CR.2009.57

1 reference

15 September 2017

1 reference